T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.68B |
| 2 |
Pinterest
PINS
|
+$2.14B |
| 3 |
Zoom
ZM
|
+$2.05B |
| 4 |
T-Mobile US
TMUS
|
+$1.98B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.78B |
Top Sells
| 1 |
Alibaba
BABA
|
+$3.74B |
| 2 |
Caterpillar
CAT
|
+$1.25B |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.24B |
| 4 |
Netflix
NFLX
|
+$1.22B |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$1.11B |
Sector Composition
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Senti Biosciences
SNTI
$35.6M
| $29.8M | ﹤0.01% |
+300,000
| New | +$29.8M |
|
1202
Royal Caribbean
RCL
$92.8B
| $29.6M | ﹤0.01% |
347,499
-2,490
| -0.7% | -$212K |
|
1203
Annexon
ANNX
$273M
| $29.5M | ﹤0.01% |
1,310,484
-28,877
| -2% | -$650K |
|
1204
Sapiens International
SPNS
$2.4B
| $29.1M | ﹤0.01% |
1,108,776
-148
| -0% | -$3.89K |
|
|
PCSB
1205
DELISTED
PCSB Financial Corporation
PCSB
| $29.1M | ﹤0.01% |
1,601,725
-10,480
| -0.7% | -$190K |
|
1206
NetApp
NTAP
$24.7B
| $28.8M | ﹤0.01% |
351,729
-12,890
| -4% | -$1.05M |
|
1207
Douglas Dynamics
PLOW
$757M
| $28.6M | ﹤0.01% |
703,883
-66,837
| -9% | -$2.72M |
|
1208
Akero Therapeutics
AKRO
$3.49B
| $28.6M | ﹤0.01% |
1,154,203
+261,057
| +29% | +$6.48M |
|
1209
Amcor
AMCR
$19.2B
| $28.6M | ﹤0.01% |
2,494,631
-52,008
| -2% | -$596K |
|
1210
Genuine Parts
GPC
$19.7B
| $28.4M | ﹤0.01% |
224,654
-7,790
| -3% | -$985K |
|
1211
Cincinnati Financial
CINF
$24.6B
| $28.4M | ﹤0.01% |
243,557
-5,090
| -2% | -$594K |
|
1212
FS Bancorp
FSBW
$319M
| $28.3M | ﹤0.01% |
794,806
-564
| -0.1% | -$20.1K |
|
1213
Healthpeak Properties
DOC
$12.6B
| $28.3M | ﹤0.01% |
850,596
-12,590
| -1% | -$419K |
|
1214
Kimbell Royalty Partners
KRP
$1.26B
| $28.3M | ﹤0.01% |
2,203,325
-208,630
| -9% | -$2.68M |
|
|
NARI
1215
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $28.2M | ﹤0.01% |
302,766
-269,128
| -47% | -$25.1M |
|
1216
Design Therapeutics
DSGN
$341M
| $28.2M | ﹤0.01% |
1,448,968
+13,714
| +1% | +$267K |
|
1217
Innovative Industrial Properties
IIPR
$1.61B
| $28.1M | ﹤0.01% |
147,161
+3,106
| +2% | +$593K |
|
1218
Mercury Systems
MRCY
$4.39B
| $28.1M | ﹤0.01% |
423,395
-19,589
| -4% | -$1.3M |
|
1219
Sandstorm Gold
SAND
$3.44B
| $27.8M | ﹤0.01% |
3,523,384
+3,348,356
| +1,913% | +$26.4M |
|
1220
Viatris
VTRS
$11.7B
| $27.6M | ﹤0.01% |
1,933,067
-15,509
| -0.8% | -$222K |
|
1221
Aaon
AAON
$6.67B
| $27.5M | ﹤0.01% |
659,039
-41,029
| -6% | -$1.71M |
|
1222
IDEAYA Biosciences
IDYA
$2.18B
| $27.5M | ﹤0.01% |
1,309,977
+409,712
| +46% | +$8.6M |
|
1223
Provident Bancorp
PVBC
$226M
| $27.4M | ﹤0.01% |
1,680,131
-1,060
| -0.1% | -$17.3K |
|
|
AXNX
1224
DELISTED
Axonics, Inc. Common Stock
AXNX
| $27.4M | ﹤0.01% |
431,353
-29,111
| -6% | -$1.85M |
|
1225
Seagate
STX
$41.7B
| $27.3M | ﹤0.01% |
311,018
-12,000
| -4% | -$1.06M |
|